Committee to Examine Effects of Trump Administration Attack on ACA

Jul 8, 2019
Press Release

Washington, D.C. (July 9, 2019)—On Wednesday, July 10, 2019, the Committee on Oversight and Reform will hold a hearing to examine the implications of the Trump Administration’s sudden decision to reverse its own previous legal position in Texas v. United States and assert that the entire Affordable Care Act (ACA) should be overturned as unconstitutional.

 

WHERE:  2154 Rayburn House Office Building 

 

WHEN:  Wednesday, July 10, 2019

 

TIME:  10 a.m. EST

 

The hearing will be broadcast here

 

PURPOSE

 

The hearing will examine the Administration’s decision to reverse its position in Texas v. United States and assert that the entire ACA should be struck down, as well as the impact this reversal could have on millions of Americans—including those with pre-existing conditions—and the United States health care system.

 

BACKGROUND

 

  • On March 25, 2019, the Trump Administration filed a letter with the U.S. Court of Appeals hearing the Texas v. United States litigation reversing its own previous legal position and no longer defending any part of the ACA in the—an action that imperils protections for 130 million people with pre-existing conditions, would cause millions of adults to lose coverage gained under Medicaid expansion, and would destabilize the individual market—forcing millions of Americans to pay significantly more for less comprehensive coverage.

 

  • Since President Trump took office in January 2017, neither the Administration nor congressional Republicans have offered a plan to replace the ACA that would prevent significant coverage losses or the elimination of consumer protections. 

 

  • The Trump Administration’s effort to invalidate the ACA undermines its own purported policy goals, including combating the opioid epidemic, lowering prescription drug prices, and ending the HIV epidemic.

 

  • According to press accounts, this decision was driven by individuals inside the White House—including the Acting Director of the Office of Management and Budget, Russ Vought—and made over the objections of the Attorney General and the Secretary of Health and Human Services (HHS).

 

  • To investigate these reports, on May 13, 2019, Chairman Elijah Cummings and four other Chairmen sent a letter requesting an interview with Acting OMB Director Vought, but the White House declined to make him available for an interview.  On June 26, 2019, Chairman Cummings invited Vought to testify at this hearing.  OMB declined the Chairman’s invitation on July 3, 2019.

 

  • The Committee has invited policy and legal experts and four patient and consumer witnesses—Casey Dye, Peter Morley, Paul Gibbs, and Stephanie Burton—to testify on the impact of the entire health care law being struck down.

 

WITNESSES

 

Russell Vought (declined)

Acting Director
Office of Management and Budget

 

Abbe Gluck

Director and Professor of Law

Solomon Center for Health Law and Policy, Yale University Law School

 

Frederick Isasi

Executive Director

Families USA

 

Casey Dye (Patient/Consumer)

Monroeville, PA

 

Peter Morley (Patient/Consumer)

New York, NY

 

Paul Gibbs (Patient/Consumer)

West Valley, UT

 

Stephanie Burton (Patient/Consumer)

Kansas City, MO

 

David Balat (Minority Witness)

Director of the Right on Healthcare Initiative

Texas Public Policy Foundation

 

###

 
116th Congress